Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05713266 · ClinicalTrials.gov registry record
Using Data From a Multisensor Rapid Health Assessment Device to Predict Decompensation in Long COVID (AIDI)
A clinical trial, sponsored by Edith Nourse Rogers Memorial Veterans Hospital.
- Completed
- Registry status
- 204
- Enrollment target
NCT05713266: Completed study, sponsored by Edith Nourse Rogers Memorial Veterans Hospital.
NCT05713266 is a clinical trial that has completed, run by Edith Nourse Rogers Memorial Veterans Hospital. The registered enrollment target is 204 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05713266 has completed, sponsored by Edith Nourse Rogers Memorial Veterans Hospital.
- COMPLETED
- Registry status
- 204 participants
- Enrollment target
Study Summary
We are conducting a research study at the VA hospital in Bedford, MA to learn more about how a multisensor rapid health assessment device, MouthLab, can help predict or anticipate future health complications in patients with underline conditions after contracting COVID-19. The device was created by a health technology and digital medicine company called Aidar Health, Inc. MouthLab is a non-invasive, hand-held device that works like a breathalyzer. An individual breathes into the device for 60 seconds and the MouthLab gathers more than 10 vital health parameters like temperature, heart rate, SpO2, ECG, and basic lung functions. Participation in the study will last for 6 months, and the purpose is to gather health information from people who have been previously hospitalized with COVID-19. We will use the data to develop an algorithm that predicts future complications of COVID-19, especially among patients with complex conditions (i.e., heart failure, chronic kidney disease, diabetes, hypertension, asthma, chronic obstructive pulmonary disease), and enables early intervention.
Primary Outcome
All cause higher level of care healthcare utilization (hospitalization, ER, or urgent care visits within VA system)
Interventions
- DEVICE MouthLabTM
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 204 participants |
| Start Date | 2022-10-31 |
| Est. Completion | 2024-02-29 |
What the finished NCT05713266 record still lists
NCT05713266 is an observational study that tracks outcomes without assigning an intervention. The registered 204 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which MouthLabTM is the first listed.
NCT05713266 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05713266 about?
NCT05713266 is a clinical study titled "Using Data From a Multisensor Rapid Health Assessment Device to Predict Decompensation in Long COVID (AIDI)". We are conducting a research study at the VA hospital in Bedford, MA to learn more about how a multisensor rapid health assessment device, MouthLab, can help predict or anticipate future health complications in patients with underline conditions after contracting COVID-19. The device was created by ...
What is the current status of trial NCT05713266?
This trial is currently completed. The enrollment target is 204 participants. The study started on 2022-10-31. Estimated completion is 2024-02-29.
What interventions are being tested in trial NCT05713266?
The interventions under investigation include: MouthLabTM (DEVICE).
Who is sponsoring clinical trial NCT05713266?
This trial is sponsored by Edith Nourse Rogers Memorial Veterans Hospital, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03481010 · 204 participants · NA
Periacetabular Osteotomy With and Without Arthroscopic Management of Central Compartment Pathology
- NCT04249830 · 204 participants · NA
Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Young Adults
- NCT04503395 · 204 participants · NA
ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES
- NCT04793776 · 204 participants · NA
Manage Emotions to Reduce Aggression (MERA)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI